NYSE Euronext’s global derivatives average daily volume (ADV) of 7.0 million contracts in February 2012 represented a decrease of 21.4% versus the prior year.

European derivatives products ADV in February 2012 of 2.8 million contracts decreased 35.7% compared to February 2011 and decreased 11.9% from January 2012 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 36.7% compared to February 2011 and decreased 6.7% from January 2012. 

NYSE Euronext US equity options ADV of 4.1 million contracts in February 2012 decreased 9.2% compared to February 2011 levels and decreased 1.5% from January 2012. NYSE Euronext’s US options exchanges accounted for 25.4% of total US consolidated equity options trading in February 2012, down from 25.9% in February 2011 and down from 26.6% in January 2012. 

NYSE Liffe US ADV of approximately 88,600 contracts increased from 12,200 contracts in February 2011, but decreased from 94,900 contracts in January 2012.

NYSE Euronext European cash products ADV of 1.6 million transactions in February 2012 decreased 8.7% compared to February 2011, but increased 7.1% from January 2012 levels. 

NYSE Euronext US cash products handled ADV of 1.8 billion shares in February 2012 decreased 21.0% compared to February 2011 and decreased 2.2% compared to January 2012.  NYSE Euronext’s Tape A matched market share in February 2012 was 30.0%, down from 34.5% in February 2011 and down slightly from 30.3% in January 2012.  There were a total of 21 trading days in Europe and 20 trading days in the US in February 2012 compared to 20 trading days in Europe and 19 trading days in the US in February 2011.